1. Home
  2. Programs
  3. ESC Action Center

Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis

David Mazer at ESC
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters

  • Overview

    ESC 2024 - In the SLICE-CEA CardioLink-8 study, evolocumab reduced lipid-rich necrotic core volume in patients with severe, asymptomatic carotic artery stenosis compared with placebo. “It suggests that intensive lipid lowering with evolocumab can stablize vulnerable plaques”, says C. David Mazer.

  • Educational information

    This video was recorded during the ESC Congress 2024 in London, UK.

  • Faculty

    C. David Mazer is a professor in the Department of Anesthesia and Physiology at the University of Toronto in Toronto, ON, Canada.

  • Disclaimer

    This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

    Read our summary of SLICE-CEA CardioLink-8

    Release date: 11 September 2024

Recommended
Details
Presenters

  • Overview

    ESC 2024 - In the SLICE-CEA CardioLink-8 study, evolocumab reduced lipid-rich necrotic core volume in patients with severe, asymptomatic carotic artery stenosis compared with placebo. “It suggests that intensive lipid lowering with evolocumab can stablize vulnerable plaques”, says C. David Mazer.

  • Educational information

    This video was recorded during the ESC Congress 2024 in London, UK.

  • Faculty

    C. David Mazer is a professor in the Department of Anesthesia and Physiology at the University of Toronto in Toronto, ON, Canada.

  • Disclaimer

    This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

    Read our summary of SLICE-CEA CardioLink-8

    Release date: 11 September 2024

Program Chapters

Segment Chapters

Playlist:

Recommended

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
PrevNext